ArticleNeoplasia (New York, N.Y.)2023

S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas.

A Mehdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.